Aponvie 32 mg/4.4 mL (7.2 mg/mL) injection Images
Generic Name: aprepitant
This medication has been identified as Aponvie 32 mg/4.4 mL (7.2 mg/mL) injection. It is supplied by Heron Therapeutics, Inc.
Aponvie is used in the treatment of Nausea/Vomiting, Postoperative; Nausea/Vomiting and belongs to the drug class NK1 receptor antagonists. There is no proven risk in humans during pregnancy. Aponvie 32 mg/4.4 mL (7.2 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Aponvie
- Generic Name
- aprepitant
- Strength
- 32 mg/4.4 mL (7.2 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- NK1 receptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Heron Therapeutics, Inc.
- National Drug Code (NDC)
- 47426-0401
More about Aponvie (aprepitant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: NK1 receptor antagonists
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.